home All News open_in_new Full Article

Devonian Announces the Filing of a New Patent Application Relating to the Use of Thykamine™ as an Antifibrotic Agent

QUEBEC CITY — Devonian Health Group Inc. (“Devonian” or the “Company”) (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on developing unique solutions to inflammatory diseases, announces the filing of a new patent application directed to the use of Thykamine™ as an antifibrotic agent. Backed by in vivo data, the patent application displays the […]


today 67 h. ago attach_file Other

attach_file Other
attach_file Events
attach_file Other
attach_file Other
attach_file Economics
attach_file Culture
attach_file Other
attach_file Other
attach_file Other
attach_file Events
attach_file Politics
attach_file Culture
attach_file Events
attach_file Other
attach_file Culture
attach_file Events
attach_file Other
attach_file Events
attach_file Events
attach_file Events


ID: 206057300
Add Watch Country

arrow_drop_down